Executive Editor:
 Managing Editor:
Publisher:
Contributing Editors:



Design/Copy Editor:
  CHRISTOPHER PEREZ  
  KENDALL KIRSCH
  NAKINA WEBSTER
  ANNE LAMBERT
  LISA BRAUER
  ELEANOR ROBERTS
  MARY ANN STEPHENS
  CAROLYN CROWN
What do you want to see in Clinical Compass™?
ASK THE EDITORS
  Last Issue - 02.12.08   Next Issue - 03.11.08  

www.neuroscienceCME.com        
Subscribe to Clinical Compass™ VOLUME 3, ISSUE 5 - FEBRUARY 26, 2008
LIVE CME/CE
Multidisciplinary CE Credits Offered!

View our full CME calendar online!

Evaluating the Impact of Medicare Part D on Persons with Severe Mental Illness

Webcast
Date: TOMORROW!
Wednesday, February 27, 2008
Time: 12:00-1:00 p.m. ET

MODERATOR
Daniel Carpenter, PhD
Daniel Carpenter, PhD

FACULTY
Carol L. Alter, MD
Carol L. Alter, MD
Elizabeth V. Delesante, MD
Elizabeth V. Delesante, MD

Register Now!
Download Course Materials


Atypicals in Practice: Case Studies on Dosing

Satellite Television Broadcast, Webcast, Telephone Simulcast
Premiere Date:
Wednesday, March 5, 2008

MODERATOR
Charles B. Nemeroff, MD, PhD
Charles B. Nemeroff, MD, PhD

FACULTY
Stephen R. Marder, MD
Stephen R. Marder, MD
Sheldon H. Preskorn, MD
Sheldon H. Preskorn, MD

Register Now!


neuroscienceCME Journal Club - Featured Article: Shift work and inter-individual differences in sleep and sleepiness

Audioconference + Webcast
Live Webcast:
Monday, March 10, 2008

GUEST
HOST

Thomas Roth, PhD
Thomas Roth, PhD
FEATURED
AUTHOR

Hans P. A. Van Dongen, PhD
Hans P. A. Van Dongen, PhD

Register Now!


neuroscienceCME Journal Club - Featured Article: American time use survey: sleep time and its relationship to waking activities

Audioconference + Webcast
Live Webcast:
Monday, April 14, 2008

GUEST
HOST

Thomas Roth, PhD
Thomas Roth, PhD
FEATURED
AUTHOR

David F. Dinges, PhD
David F. Dinges, PhD

Register Now!


neuroscienceCME Journal Club - Posttreatment Outcomes: Combined Pharmacotherapy and Psychosocial Intervention

Audioconference + Webcast
Live Webcast:
Monday, May 12, 2008

GUEST
HOST

Kyle M. Kampman, MD
Kyle M. Kampman, MD
FEATURED
AUTHOR

Dennis Donovan, PhD
Dennis Donovan, PhD

Register Now!

SELF-STUDY CME/CE
Multidisciplinary CE Credits Offered!

View our full library of complimentary self-study CE materials!

Addressing Clinical Challenges in the Long-Term Treatment of Schizophrenia

Podcast
Released: Friday, February 22, 2008

FACULTY
Charles B. Nemeroff, MD, PhD
Peter F. Buckley, MD
Stephen R. Marder, MD
John W. Newcomer, MD


Participate
Combating the Consequences of Excessive Sleepiness

Archived Videoconference
Released December 5, 2007

FACULTY
Charles B. Nemeroff, MD, PhD
David F. Dinges, PhD
Thomas Roth, PhD


Participate    Order Online
Waking Up to the Problem of OSA: Consequences and Improved Recognition

Archived Audioconference
Released October 16, 2007

FACULTY
Sonia Ancoli-Israel, PhD
Barbara A. Phillips, MD, MSPH, FCCP


Participate    Order Online
Practical Management Options for Alcohol Dependence, Part 3 of 3 - Initiating Pharmacotherapy in Patients with Alcohol Dependence

Monograph
Released December 19, 2007

FACULTY
Kyle M. Kampman, MD


Participate    Order Online


FROM THE MAJOR DEPRESSIVE DISORDER CLINICAL KNOWLEDGE CENTER:
Treating Depression and Getting to the Heart of the Matter
 

THIS ISSUE'S COMPASS QUESTIONS™ 

RESPONSES FROM OUR LAST COMPASS QUESTIONS™ 

LIVE Q&A neuroscienceCME WEBCAST TOMORROW! 

NEW neuroscienceCME TV PREMIERES NEXT WEEK! 


FROM THE MAJOR DEPRESSIVE DISORDER CLINICAL KNOWLEDGE CENTER
Treating Depression and Getting to the Heart of the Matter
The reciprocal link between coronary heart disease (CHD) and depression has been well documented: people with a history of depression are more likely to experience a cardiac event, such as myocardial infarction (MI), and people who have experienced a cardiac event commonly develop depression. The elevated risk of another cardiac event in patients with depression extends beyond five years. Not only are people with depression more likely to have subsequent cardiac problems, they are more likely to have a fatal recurrent cardiac event rather than a nonfatal event...

Read entire article

Back to top



THIS ISSUE'S COMPASS QUESTIONS™
Your responses to this issue's Compass Questions™ will be added to an ongoing needs assessment for educational programming in this important area. Responses to this issue's questions will be reported in an upcoming issue.

Question #1: What do you feel is the most important issue to address in improving your practice for patients with co-occurring coronary heart disease (CHD) and depression?
Educating cardiologists and primary care physicians on assessment tools for routine screening of depression in their patients, and/or on treating or referral as appropriate
Education about potentially harmful antidepressant-cardiac drug interaction and monitoring
Education on the pathophysiology linking depression and CHD
Education on balancing efficacy and side effect profiles of antidepressants and second-line agents in the context of CHD

Question #2: How confident are you in aggressively managing treatment-refractory depression with changes in pharmacotherapy, such as increasing, switching or augmenting medications within the context of MI?
Extremely
Very
Somewhat
Id like more education on managing pharmacotherapy in patients with co-occurring depression and MI



Back to top

RESPONSES FROM OUR LAST COMPASS QUESTIONS™
In the 01.29.08 issue of Clinical Compass™, we asked two questions. Question #1 was "What proportion of patients with depression do you see who also have coronary heart disease?" and the neuroscienceCME learning community responded:
10% - Most
42% - About half
35% - Very few
13% - Don't know

Question #2 was "How do you typically treat patients with depression who have experienced myocardial infarction or another significant cardiac event?" and the neuroscienceCME learning community responded:
5% - Treat depression with psychotherapy or counseling only
77% - Treat depression with psychotherapy/counseling and an antidepressant
10% - Treat depression with antidepressant only
8% - Other

Back to top


LIVE Q&A neuroscienceCME WEBCAST TOMORROW!
Evaluating the Impact of Medicare Part D on Persons with Severe Mental Illness

Date: Wednesday, February 27, 2008
Time: 12:00-1:00 p.m. ET
(Please note, participation in this activity will ONLY be possible via webcast. Visit the links below to register and participate.)

ACTIVITY GOAL
The goal of this activity is to educate practitioners about the impact of Medicare Part D on patients with severe mental illness and to provide guidance on strategies for delivering optimal care to these patients in light of policy restrictions.

LEARNING OBJECTIVES
At the end of this CE activity, participants should be able to:
  • Identify the ways in which Medicare Part D impacts patients.
  • Describe the clinical challenges posed by Medicare Part D.
  • Delineate strategies for obtaining Medicare authorization for optimal pharmacotherapy.
CREDIT INFORMATION
This activity offers CE credit for:
  • Physicians (ACCME/AMA PRA Category 1)
  • Nurses (CNE)
  • Pharmacists (ACPE)
  • Psychologists (APA)
  • Social Workers (NASW)
  • Certified Case Managers (CCMC)
All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.

View Activity Details    Register Now! 

Back to top


NEW neuroscienceCME TV PREMIERES NEXT WEEK!
Atypicals in Practice: Case Studies on Dosing

Premiere Date: Wednesday, March 5, 2008
Live Broadcast: 12:00-1:00 p.m. ET
Taped Re-Air: 3:00-4:00 p.m. ET

ACTIVITY GOAL
To apply concepts related to the pharmacokinetics and pharmacodynamics of atypical antipsychotics to patient cases and to review current evidence on dosing strategies.

LEARNING OBJECTIVES
At the end of this CE activity, participants should be able to:
  • Compare and contrast atypical antipsychotics with respect to receptor binding and clinical pharmacology.
  • Evaluate atypical antipsychotics in terms of pharmacokinetic considerations related to dosing.
  • Apply techniques from patient case vignettes to optimize outcomes with appropriate dose selection regimen.
View Activity Details    Register Now! 

Don't forget about the neuroscienceCME TV archive:
Atypicals in Practice: Case Studies on Switching

Credit Expiration Date: Friday, November 7, 2008

ACTIVITY GOAL
To utilize appropriate switching techniques for patients who do not achieve the optimal therapeutic response or have treatment emergent side effects.

LEARNING OBJECTIVES
At the end of this CE activity, participants should be able to:
  • Describe factors that lead to discontinuation of atypical antipsychotics.
  • Identify treatment-emergent side effects that may necessitate a strategy for switching antipsychotic therapy.
  • Employ techniques for switching antipsychotics that minimize risk and improve patient outcomes.
View Activity Details    Register Now! 

CREDIT INFORMATION
Both of the above neuroscienceCME TV activities offer CE credit for:
  • Physicians (ACCME/AMA PRA Category 1)
  • Nurses (CNE)
  • Pharmacists (ACPE)
  • Psychologists (APA)
  • Social Workers (NASW)
  • Certified Case Managers (CCMC)
All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.


Back to top




Problems receiving e-mail from us? Add webmaster@cmeoutfitters.com to your address book.

CME Outfitters, LLC, reserves the right to cancel any activity or make necessary changes in dates, times, speakers, content, and other details without notice. CME Outfitters, LLC, and the commercial supporters of these activities are not responsible for any speaker's or registrant's statements, materials, acts, or omissions.

©2008 CME Outfitters, LLC